Sector Chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.070 USD | +3.88% |
|
-6.14% | -35.93% |
| 07-14 | Lineage Cell Therapeutics, Inc. - Special Call | |
| 07-13 | Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 267M | - | - | - | ||
| 47.88B | |||||
| 39.09B | - | - | - | - | - |
| 36.75B | |||||
| 40.55B | |||||
| 27.96B |
Select your edition
All financial news and data tailored to specific country editions
